Resource Guide: Follow-up care timeline for Fosamax-related Osteonecrosis of the Jaw

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Featured analysis

Follow-up care timeline for Fosamax-related Osteonecrosis of the Jaw — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.